Cargando…
Prdx5 in the Regulation of Tuberous Sclerosis Complex Mutation-Induced Signaling Mechanisms
(1) Background: Tuberous sclerosis complex (TSC) mutations directly affect mTORC activity and, as a result, protein synthesis. In several cancer types, TSC mutation is part of the driver mutation panel. TSC mutations have been associated with mitochondrial dysfunction, tolerance to reactive oxygen s...
Autores principales: | Bovari-Biri, Judit, Abdelwahab, ElHusseiny Mohamed Mahmoud, Garai, Kitti, Pongracz, Judit E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340296/ https://www.ncbi.nlm.nih.gov/pubmed/37443747 http://dx.doi.org/10.3390/cells12131713 |
Ejemplares similares
-
Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited
por: Abdelwahab, ElHusseiny M. M., et al.
Publicado: (2021) -
Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations
por: Abdelwahab, Elhusseiny Mohamed Mahmoud, et al.
Publicado: (2021) -
miRNAs as Predictors of Barrier Integrity
por: Bovari-Biri, Judit, et al.
Publicado: (2023) -
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
por: Jaromi, Luca, et al.
Publicado: (2021) -
Preparation and Characterization of ACE2 Receptor
Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce
the Risk of COVID-19 Viral Infection
por: Vörös-Horváth, Barbara, et al.
Publicado: (2022)